Accuracy of Clinical Stage in Resectable Non-small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Gwon, H. R. [1 ]
机构：
[1] Yonsei Univ Med, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
NSCLC; clinical stage; staging accuracy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP13.01-00
引用
收藏
页码：S520 / S521
页数：2
相关论文
共 50 条
  • [1] Role of chemokines in resectable non-small cell lung cancer (NSCLC)
    Drosslerova, M.
    Sterclova, M.
    Vasakova, M.
    Taskova, A.
    Hytych, V.
    Horazd'ovsky, P.
    Richterova, E.
    Smetakova, M.
    Havel, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Chemokines, Their Gene Polymorphisms in Resectable Non-Small Cell Lung Cancer (NSCLC)
    Drosslerova, M.
    Sterclova, M.
    Vasakova, M.
    Taskova, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [3] Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
    Chiu, Li-Chung
    Lin, Shu-Min
    Lo, Yu-Lun
    Kuo, Scott Chih-Hsi
    Yang, Cheng-Ta
    Hsu, Ping-Chih
    VACCINES, 2021, 9 (07)
  • [4] Treatment of resectable stage IIIA non-small cell lung cancer
    Cardenal, Felipe
    Palmero, Ramon
    JOURNAL OF THORACIC DISEASE, 2017, 9 (01) : 13 - 15
  • [5] Temporal trends in clinical and pathologic stage discordance in resectable non-small cell lung cancer
    Santos, Giordano Fabricio Cittolin
    Knapp, Brendan
    Flanagan, Mary Ellen
    Tohmasi, Steven
    Kozower, Benjamin D.
    Meyers, Bryan F.
    Govindan, Ramaswamy
    Puri, Varun
    Morgensztern, Daniel
    Brandt, Whitney S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC)
    De Ruysscher, D.
    LUNG CANCER, 2009, 64 : S21 - S21
  • [7] Paclitaxel, gemcitabin, and cisplatin in non-resectable non-small cell lung cancer (NSCLC)
    Sorensen, JB
    Stenbygaard, LE
    Hansen, HH
    Osterlind, K
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S258 - S258
  • [8] Use of postoperative radiotherapy (PORT) for resectable non-small cell lung cancer (NSCLC)
    Bekelman, JE
    Rosenzweig, KE
    Bach, PB
    Schrag, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S117 - S118
  • [9] Neoadjuvant atezolizumab plus chemotherapy in resectable non-small cell lung cancer (NSCLC).
    Shu, Catherine A.
    Grigg, Claud
    Chiuzan, Codruta
    Garofano, Robert F.
    Patel, Vijeta
    Hernandez, Susana
    Negri, Tiffany
    Sacher, Adrian G.
    Smith-Marrone, Stephanie
    Stoopler, Mark
    Gainor, Justin F.
    Awad, Mark M.
    D'Ovidio, Frank
    Sonett, Joshua R.
    Bacchetta, Matthew
    Saqi, Anjali
    Rizvi, Naiyer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Interim Analysis of Neoadjuvant Chemoradiotherapy and Durvalumab for Potentially Resectable Stage III Non-Small Cell Lung Cancer (NSCLC)
    Hong, M. H.
    Ahn, B.
    Kim, H. R.
    Lim, S. M.
    Lee, S.
    Park, S. Y.
    Lee, C. Y.
    Lee, J. G.
    Kim, D. J.
    Lee, S. H.
    Yoon, H. I.
    Lee, C. G.
    Cho, J.
    Shim, H. S.
    Kim, T.
    Cho, B. C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S194 - S195
12345